Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Curaleaf Holdings ( (TSE:CURA) ).
Curaleaf Holdings has called an annual general and special shareholders’ meeting for June 22, 2026, to be conducted exclusively via live webcast, with May 5, 2026 set as the record date for voting eligibility. Shareholders are instructed to submit proxies or voting instructions by June 18, 2026, and non-registered holders must follow intermediary procedures to appoint proxyholders or attend as guests.
At the meeting, investors will vote on the 2025 audited financial statements, the election of ten directors, the appointment of BDO USA as auditor, continued use of the 2018 Stock and Incentive Plan, amendments to the company’s share capital, and a stock option–to–RSU exchange program. They will also consider a plan of arrangement to continue the company’s corporate domicile from British Columbia to Delaware, with registered shareholders granted statutory dissent rights under the Business Corporations Act (British Columbia) and related court orders issued in May 2026.
The most recent analyst rating on (TSE:CURA) stock is a Buy with a C$6.50 price target. To see the full list of analyst forecasts on Curaleaf Holdings stock, see the TSE:CURA Stock Forecast page.
Spark’s Take on CURA Stock
According to Spark, TipRanks’ AI Analyst, CURA is a Neutral.
Overall score reflects strong technical momentum and attractive P/E valuation, balanced against a still-developing fundamental profile (ongoing net losses and leverage). The earnings call added support via improving results, constructive guidance, and refinancing progress, partially offset by margin compression and working-capital/cash-flow pressures.
To see Spark’s full report on CURA stock, click here.
More about Curaleaf Holdings
Curaleaf Holdings, Inc. is a cannabis company operating in the regulated marijuana and hemp-derived products industry. The firm focuses on cultivating, processing and retailing cannabis-based products, serving both medical and adult-use markets across North America, and is listed as a foreign private issuer with its principal executive offices in Vancouver, British Columbia.
YTD Price Performance: 37.54%
Average Trading Volume: 837,962
Technical Sentiment Signal: Buy
Current Market Cap: C$3.63B
See more data about CURA stock on TipRanks’ Stock Analysis page.